Utility of LDCT in Lung Cancer Screening in a TB Endemic Region

NACompletedINTERVENTIONAL
Enrollment

253

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

December 31, 2021

Conditions
Lung Cancer
Interventions
DIAGNOSTIC_TEST

Low-dose computed tomography of chest

Eligible subjects will undergo a single round of LDCT screening. The LDCT will be considered as positive if a solid nodule or part-solid nodule of size ≥6 mm or non-solid nodule of size ≥20 mm is identified. Evaluation of positive nodules will be performed as per existing standard recommendations

Trial Locations (1)

160012

Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT03909620 - Utility of LDCT in Lung Cancer Screening in a TB Endemic Region | Biotech Hunter | Biotech Hunter